Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
2.
Eur Respir Rev ; 30(160)2021 Jun 30.
Article in English | MEDLINE | ID: covidwho-1218291

ABSTRACT

Prone positioning reduces mortality in the management of intubated patients with moderate-to-severe acute respiratory distress syndrome. It allows improvement in oxygenation by improving ventilation/perfusion ratio mismatching.Because of its positive physiological effects, prone positioning has also been tested in non-intubated, spontaneously breathing patients, or "awake" prone positioning. This review provides an update on awake prone positioning for hypoxaemic respiratory failure, in both coronavirus disease 2019 (COVID-19) and non-COVID-19 patients. In non-COVID-19 acute respiratory failure, studies are limited to a few small nonrandomised studies and involved patients with different diseases. However, results have been appealing with regard to oxygenation improvement, especially when combined with noninvasive ventilation or high-flow nasal cannula.The recent COVID-19 pandemic has led to a major increase in hospitalisations for acute respiratory failure. Awake prone positioning has been used with the aim to prevent intensive care unit admission and mechanical ventilation. Prone positioning in conscious, non-intubated COVID-19 patients is used in emergency departments, medical wards and intensive care units.Several trials reported an improvement in oxygenation and respiratory rate during prone positioning, but impacts on clinical outcomes, particularly on intubation rates and survival, remain unclear. Tolerance of prolonged prone positioning is an issue. Larger controlled, randomised studies are underway to provide results concerning clinical benefit and define optimised prone positioning regimens.


Subject(s)
COVID-19/therapy , Lung/physiopathology , Patient Positioning , Prone Position , Respiratory Insufficiency/therapy , Wakefulness , COVID-19/physiopathology , COVID-19/virology , Humans , Lung/virology , Recovery of Function , Respiration , Respiratory Insufficiency/physiopathology , Respiratory Insufficiency/virology , Treatment Outcome
3.
ClinicalTrials.gov; 08/04/2020; TrialID: NCT04344106
Clinical Trial Register | ICTRP | ID: ictrp-NCT04344106

ABSTRACT

Condition:

Coronavirus Infection;Oxygen Deficiency

Intervention:

Procedure: Prone positioning

Primary outcome:

Proportion of "responder" patients to prone position

Criteria:


Inclusion Criteria:

- Patient aged at least 18 years;

- Hospitalized in a COVID unit or intensive care unit;

- Spontaneously breathing and with oxygen therapy with nasal canula, mask or High Flow
Oxygen Therapy;

- Requiring oxygen therapy = 1l for Sat = 90%;

- COVID 19 positive in RT-PCR or diagnosis on clinicals symptoms and highly evocatives
scannographics lesions in an epidemic period;

- Chest scanner without injection within 72 hours prior to inclusion;

- Bilateral scannographic lesions, including posterior condensations and/or posterior
predominance of lesions;

- Patient benefiting from French social security, under any regime

Exclusion Criteria:

- acute respiratory distress (polypnea >25 or use of accessory respiratory muscles);

- Alteration of consciousness;

- Active or recent hemoptysis (<1 month);

- Recent Thrombo-Embolic Venous Disease (< 1 month);

- Pericardial effusion;

- Pleural effusion of high abundance, clinical or scannographic;

- Chronic back or cervical pain/ history of spinal surgery/ bone metastases;

- Wounds, facial trauma, tracheal, sternal or facial surgery < 15 days;

- Recent abdominal surgery (< 1 month);

- Intracranial HyperTension > 30mmHg;

- Patient deprived of liberty, under guardianship or curatorship;

- Pregnant or lactating woman.


SELECTION OF CITATIONS
SEARCH DETAIL